Icosavax, Inc. (ICVX) NASDAQ

15.31

-0.14(-0.91%)

Updated at February 16, 2024 04:00PM

Currency In USD

Valuation

Market Cap315.42M
Enterprise Value265.37M
P/E Ratio-6.88
PEG Ratio-0.07
Price/Sales Ratio1,321.37
Price/Book Ratio2.79
Enterprise/Revenue1,235.37
Enterprise/EBITDA-7.63

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin-151.99
Operating Margin-163.33

Management Effectiveness

Return On Assets-0.37
Return On Equity-0.36

Income Statement

Revenue582,000
Revenue/Share0.01
Gross Profit-1.26M
EBITDA-94.2M
Net Income-88.46M
Diluted EPS-2.23

Balance Sheet

Total Cash229.21M
Total Cash/Share5.5
Total Debt8.07M
Total Debt/Equity0.04
Current Ratio16.24
Book Value Per Share5.49

Price History

52-Week Change138.85
52-Week High16.11
52-Week Low4.75
Moving Average 50 Days14.98
Moving Average 200 Days10.02

Statistics

Average Volume1.05M
Shares Outstanding50.23M
% Held by Institutions84.02

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A